Fundraising Fox

Seneca Therapeutics

Blue Bell, US · Founded 2018 · Delaware corporation

Biotech

Founders & leadership

Seneca Therapeutics was founded in 2018 by Paul Hallenbeck.

PH
Paul HallenbeckinFounderFounder, President and Chief Scientific Officer at Seneca Therapeutics, Inc Biotechnology
CDCuong Do
Cuong DoinExecutivePresident, Samsung Corporate Strategy Group at AIF
JH
James HusseyinExecutive

Board

MK
Mark KerschnerBoard director

Reported raises · per SEC filings

Form D private placements

$11M disclosed across 5 of 6 rounds · 2019–2024

▶$1.6MraisedFeb 2025 · 68 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Cuong DoExecutive Officer, Director
  • Mark KerschnerDirector
  • Paul HallenbeckExecutive Officer, Director
  • James HusseyExecutive Officer, Director
Offering amount
$8M
Amount sold
$1.6M
Sales commissions
$65.5K
Placement agents
Walter Greenblatt & Associates, LLC
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.7MraisedDec 2022 · 114 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James HusseyExecutive Officer, Director
  • Paul HallenbeckExecutive Officer, Director
  • Mark KerschnerExecutive Officer, Director
Offering amount
$12.8M
Amount sold
$7.7M
Sales commissions
$423.5K
Proceeds to insiders
$400K
Placement agents
Walter Greenblatt & Associates, LLC
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$501KraisedJun 2020 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul HallenbeckExecutive Officer, Director
Offering amount
$3.3M
Amount sold
$501K
Sales commissions
$227.5K
Proceeds to insiders
$150K
Placement agents
Walter Greenblatt & Associates, LLC
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$820KraisedMar 2020 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul HallenbeckExecutive Officer, Director
Offering amount
$1M
Amount sold
$820K
Sales commissions
$70K
Proceeds to insiders
$33.7K
Placement agents
Walter Greenblatt & Associates, LLC
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$380KraisedAug 2019 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul HallenbeckExecutive Officer, Director
Offering amount
$500K
Amount sold
$380K
Sales commissions
$35K
Proceeds to insiders
$90.4K
Placement agents
Walter Greenblatt & Associates, LLC
First sale
May 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Seneca Therapeutics Announces the Closing of $3.9 million Series B Extension Round — Seneca Therapeuticssenecatherapeutics.com · Sep 2025Seneca Therapeutics Garners Prestigious Recognition at Keiretsu Forum’s Investor Capital Expo — Seneca Therapeuticssenecatherapeutics.com · Oct 2023Money Moves: 3 Philly biotech companies are starting 2023 with fresh funding - Technical.lytechnical.ly · Jan 2023Blue Bell-based Seneca Therapeutics raises $5M, eyes new funding round - Philadelphia Business Journalbizjournals.com · Jan 2022

Frequently asked questions

Who founded Seneca Therapeutics?
Seneca Therapeutics was founded by Paul Hallenbeck in 2018.
How much funding has Seneca Therapeutics raised?
Seneca Therapeutics has disclosed $11M raised across 5 of its 6 known rounds.
Where is Seneca Therapeutics headquartered?
Seneca Therapeutics is headquartered in Blue Bell, US.